AKAP 220 Antibodies

Santa Cruz Biotechnology features a diverse variety of AKAP 220 monoclonal antibodies for research focused on understanding cellular signaling mechanisms. AKAP 220 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). AKAP 220, also known as A-kinase anchoring protein 220, plays a crucial role in the organization of signaling complexes within cells, particularly in the regulation of protein kinase A (PKA) signaling pathways. By anchoring PKA to specific cellular locations, AKAP 220 facilitates precise signaling events that are vital for processes such as cell growth, differentiation, and response to hormonal signals. Understanding AKAP 220 function is essential for elucidating its involvement in various physiological and pathological conditions. AKAP 220 research has revealed significant insights into cellular communication networks and regulatory mechanisms. Ongoing studies continue to uncover new aspects of AKAP 220's role in health and disease. AKAP 220 monoclonal antibodies from Santa Cruz Biotechnology enable researchers worldwide to advance our understanding of cellular signaling pathways and contribute to meaningful scientific discoveries.